Identification of critical transcriptomic signaling pathways in patients with H syndrome and Rosai-Dorfman disease

Samuel Lara-Reyna, James A Poulter, Elton J R Vasconcelos, Mark Kacar, Michael F McDermott, Reuben Tooze, Rainer Doffinger, Sinisa Savic

Research output: Contribution to journalArticlepeer-review

98 Downloads (Pure)

Abstract

Biallelic mutations in SLC29A3 cause histiocytosis-lymphadenopathy plus syndrome, also known as H syndrome (HS). HS is a complex disorder, with ~ 25% of patients developing autoinflammatory complications consisting of unexplained fevers, persistently elevated inflammatory markers, and unusual lymphadenopathies, with infiltrating CD68+, S100+, and CD1a- histiocytes, resembling the immunophenotype found in Rosai-Dorfman disease (RDD). We investigated the transcriptomic profiles of monocytes, non-activated (M0), classically activated (M1), and alternatively activated macrophages (M2) in two patients with HS, one without autoinflammatory (HS1) and one with autoinflammatory complications (HS2). RNA sequencing revealed a dysregulated transcriptomic profile in both HS patients compared to healthy controls (HC). HS2, when compared to HS1, had several differentially expressed genes, including genes associated with lymphocytic-histiocytic predominance (e.g. NINL) and chronic immune activation (e.g. B2M). The transcriptomic and cytokine profiles of HS patients were comparable to patients with SAID with high levels of TNF. SERPINA1 gene expression was found to be upregulated in all patients studied. Moreover, higher levels of IFNγ were found in the serum of both HS patients when compared to HC. Gene ontology (GO) enrichment analysis of the DEGs in HS patients revealed the terms "type I IFN," "IFNγ signaling pathway," and "immune responses" as the top 3 most significant terms for monocytes. Gene expression analysis of lymph node biopsies from sporadic and H syndrome-associated RDD suggests common underlying pathological process. In conclusion, monocytes and macrophages from both HS patients showed transcriptomic profiles similar to SAIDs and also uniquely upregulated IFNγ signature. These findings may help find better therapeutic options for this rare disorder.

Original languageEnglish
Pages (from-to)441-457
Number of pages17
JournalJournal of Clinical Immunology
Volume41
Issue number2
Early online date7 Dec 2020
DOIs
Publication statusPublished - Feb 2021

Bibliographical note

Funding Information:
This study was partially funded by unrestricted research grant from SOBI pharmaceuticals. SS is supported by EU Horizon 2020 research and innovation program (ImmunAID; grant agreement number 779295).

The authors would like to thank the patients who participated in this research and colleagues from the Department of Clinical Immunology and Allergy, St James's University Hospital, Leeds.

Publisher Copyright:
© 2020, The Author(s).

Keywords

  • H syndrome
  • systemic autoinflammatory disease
  • interferon gamma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Identification of critical transcriptomic signaling pathways in patients with H syndrome and Rosai-Dorfman disease'. Together they form a unique fingerprint.

Cite this